Table 2 Human papillomavirus seroprevalence by genus and mean number (SD) of HPV seropositivty per Caucasian transplant patient across genus (N = 425)
From: The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK
| Mean (SD) number of HPV seropositivity per patient and by genus | ||||||
|---|---|---|---|---|---|---|
| alpha | beta | gamma | other | |||
|
Number of HPV seropositive patients (%) N = 425 | (7 types) | (16 types) | (6 types) | (5 types) | ||
| Seropositivity to: | ||||||
| Any types | 366 (86) | 1.0 (1.3) | 2.4 (3.7) | 1.0 (1.4) | 0.8 (1.1) | |
| alpha mucosal | ||||||
| 0 | 250 (59) | 1.9 (3.3) | 0.8 (1.2) | 0.6 (0.9) | ||
| 1 | 127 (30) | 2.2 (3.4) | 1.1 (1.5) | 0.8 (1.0) | ||
| ≥ 2 | 48 (11) | 5.3 (5.1) | 2.0 (1.7) | 1.4 (1.4) | ||
| alpha cutaneous | ||||||
| 0 | 285 (67) | 1.6 (2.8) | 0.7 (1.1) | 0.6 (0.9) | ||
| 1 | 92 (22) | 2.6 (3.6) | 1.2 (1.5) | 0.7 (1.0) | ||
| ≥ 2 | 48 (11) | 6.8 (5.5) | 2.6 (1.8) | 1.8 (1.6) | ||
| beta | ||||||
| 0 | 188 (44) | 0.6 (0.8) | 0.4 (0.8) | 0.4 (0.7) | ||
| 1 | 76 (18) | 0.8 (0.9) | 0.5 (0.7) | 0.5 (0.8) | ||
| 2/3 | 76 (18) | 1.3 (1.5) | 1.2 (1.4) | 0.6 (0.9) | ||
| ≥ 4 | 85 (20) | 2.0 (1.8) | 2.7 (1.7) | 1.8 (1.4) | ||
| gamma | ||||||
| 0 | 225 (53) | 0.7 (0.9) | 0.8 (1.5) | 0.4 (0.6) | ||
| 1 | 92 (22) | 1.0 (1.2) | 1.7 (2.2) | 0.9 (1.0) | ||
| ≥ 2 | 108 (15) | 1.9 (1.7) | 6.1 (5.2) | 1.5 (1.4) | ||
| other types | ||||||
| 0 | 233 (55) | 0.8 (1.1) | 1.2 (2.2) | 0.6 (1.0) | ||
| 1 | 107 (25) | 1.0 (1.1) | 2.3 (3.5) | 1.0 (1.4) | ||
| ≥ 2 | 85 (20) | 1.8 (1.8) | 5.6 (5.2) | 2.3 (1.8) | ||
